Showing results (21-30 of 242) with videos related to
Sort By:
Pageof 25
Pharmacology & Therapeutics|August 23, 2002
Toward the rational design of protein kinase casein kinase-2 inhibitorsStefania Sarno, Stefano Moro, Flavio Meggio, et al.The Biochemical Journal|August 7, 2003
Eukaryotic translation-initiation factor eIF2beta binds to protein kinase CK2: effects on CK2alpha activityFranc Llorens, Nerea Roher, Francesc A Miró, et al.The Biochemical Journal|September 10, 2015
Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activityGiorgio Cozza, Sofia Zanin, Stefania Sarno, et al.Cellular and Molecular Life Sciences : CMLS|January 21, 2014
Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potentialGiorgio Cozza, Cristina Girardi, Alessandro Ranchio, et al.Cellular and Molecular Life Sciences : CMLS|July 2, 2011
Structural features underlying the selectivity of the kinase inhibitors NBC and dNBC: role of a nitro group that discriminates between CK2 and DYRK1AStefania Sarno, Marco Mazzorana, Ryan Traynor, et al.Biochemistry|July 19, 2008
The regulatory beta subunit of protein kinase CK2 contributes to the recognition of the substrate consensus sequence. A study with an eIF2 beta-derived peptideGiorgia Poletto, Jordi Vilardell, Oriano Marin, et al.Journal of Medicinal Chemistry|November 30, 2004
Optimization of protein kinase CK2 inhibitors derived from 4,5,6,7-tetrabromobenzimidazoleMario A Pagano, Mariola Andrzejewska, Maria Ruzzene, et al.Accounts of Chemical Research|June 18, 2003
The raison d'être of constitutively active protein kinases: the lesson of CK2Lorenzo A PinnaIUBMB Life|February 8, 2020
IPK2019: David Shugar and the genesis of the IPK conferencesLorenzo A PinnaPageof 25